Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Mar 1;173(3):705-10.
doi: 10.1084/jem.173.3.705.

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen

Affiliations

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen

F Rousset et al. J Exp Med. .

Abstract

Human resting B lymphocytes enter a state of sustained proliferation when incubated with both mouse fibroblastic L cells stably expressing Fc gamma RII/CDw32 and anti-CD40 antibodies. We have explored the effects of 11 recombinant human cytokines (CKs) on induced cell proliferation and immunoglobulin (Ig) production. Interleukin 4 (IL-4) was the only CK able to enhance anti-CD40-induced B cell multiplication as measured by enumeration of viable cells, and interferon gamma (IFN-gamma) further stimulated this induced proliferation. IL-4 enhanced the production of IgM and IgG by B cells and induced them to produce IgE. Combinations of IL-4 and IL-2 resulted in the production of large amounts of IgM and IgA. Interestingly, IFN-gamma did not inhibit the production of IgE by cells stimulated with anti-CD40 and IL-4. None of the tested CK combinations resulted in the production of large quantities of IgG. Therefore, this new culture system represents a unique model to study isotype regulation in highly purified human B lymphocytes, in addition to allowing the generation of long-term factor-dependent human B cell lines.

PubMed Disclaimer

References

    1. J Exp Med. 1989 Apr 1;169(4):1295-307 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5580-4 - PubMed
    1. J Exp Med. 1988 Jan 1;167(1):183-96 - PubMed
    1. Eur J Immunol. 1987 Dec;17(12):1743-50 - PubMed
    1. J Immunol. 1986 Jun 15;136(12):4538-41 - PubMed

MeSH terms